Eterna Therapeutics
ERNA
$2.00
Share price
12.99%
Change (1 day)
-36.31%
Change (1 year)
Categories
Eterna Therapeutics (ERNA) - Total debt
Total debt on the balance sheet as of December 2023 : $41.84 M
According to Eterna Therapeutics's latest financial reports the company's total debt is $41.84 M. A company’s total debt is the sum of all current and non-current debts.
Eterna Therapeutics - Total debt on balance sheet (from 2020 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $4.13 M | 51.96% |
| 2021-12-31 | $2.72 M | -6.04% |
| 2020-12-31 | $2.89 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $20.36 B | 48,575.05% | 🇫🇷 France |
 Baxter BAX | $14.17 B | 33,764.68% | 🇺🇸 USA |
 Omeros Corporation OMER | $0.34 B | 714.65% | 🇺🇸 USA |
 Geron GERN | $85.89 M | 105.29% | 🇺🇸 USA |
 Genetic Technologies GENE | $0.26 M | -99.38% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | $20.15 B | 48,063.37% | 🇮🇱 Israel |
 Bio-Techne TECH | $0.55 B | 1,228.06% | 🇺🇸 USA |